Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 453

Similar articles for PubMed (Select 8342319)

1.

Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.

Piedra PA, Glezen WP, Mbawuike I, Gruber WC, Baxter BD, Boland FJ, Byrd RW, Fan LL, Lewis JK, Rhodes LJ, et al.

Vaccine. 1993;11(7):718-24.

PMID:
8342319
2.

Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses.

Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB.

J Infect Dis. 1991 Feb;163(2):300-4.

PMID:
1988512
3.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
4.

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.

Alexandrova GI, Budilovsky GN, Koval TA, Polezhaev FI, Garmashova LM, Ghendon YuZ, Romanova YR, Smorodintsev AA.

Vaccine. 1986 Jun;4(2):114-8.

PMID:
3524050
5.

Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.

Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF.

J Infect Dis. 1993 Feb;167(2):305-11.

PMID:
8421165
6.

Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.

Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH.

J Infect Dis. 1988 Dec;158(6):1209-19.

PMID:
3198936
7.

Serum IgG subclass antibody responses in children vaccinated with influenza virus antigens by live attenuated or inactivated vaccines.

Garcon NM, Groothuis J, Brown S, Lauer B, Pietrobon P, Six HR.

Antiviral Res. 1990 Aug;14(2):109-16.

PMID:
2275526
9.

Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.

Khan AS, Polezhaev F, Vasiljeva R, Drinevsky V, Buffington J, Gary H, Sominina A, Keitel W, Regnery H, Lonskaya NL, Doroshenko E, Gavrilov A, Ivakhov I, Arden N, Schonberger LB, Couch R, Kendal A, Cox N.

J Infect Dis. 1996 Feb;173(2):453-6.

10.

Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.

Steinhoff MC, Fries LF, Karron RA, Clements ML, Murphy BR.

J Clin Microbiol. 1993 Apr;31(4):836-8.

11.

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

Squarcione S, Sgricia S, Biasio LR, Perinetti E.

Vaccine. 2003 Mar 7;21(11-12):1268-74.

PMID:
12559808
13.

[A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].

Slepushkin AN, Rudenko LG, Kendal AP, Monto AS, Beliaev AL, Burtseva EI, Grigor'eva EP, Obrosova-Serova NP, Ivanova VT, Bragina VE, et al.

Vopr Virusol. 1994 May-Jun;39(3):129-31. Russian.

PMID:
8091754
14.

Live attenuated and inactivated influenza vaccine in school-age children.

Gruber WC, Taber LH, Glezen WP, Clover RD, Abell TD, Demmler RW, Couch RB.

Am J Dis Child. 1990 May;144(5):595-600.

PMID:
2330929
16.

Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.

Steinhoff MC, Halsey NA, Wilson MH, Burns BA, Samorodin RK, Fries LF, Murphy BR, Clements ML.

J Infect Dis. 1990 Aug;162(2):394-401.

PMID:
2197335
17.

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.

Belshe RB, Swierkosz EM, Anderson EL, Newman FK, Nugent SL, Maassab HF.

J Infect Dis. 1992 Apr;165(4):727-32.

PMID:
1552202
18.

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group.

Pediatr Infect Dis J. 2001 Dec;20(12):1124-31.

PMID:
11740317
20.

Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study.

Gruber WC, Campbell PW, Thompson JM, Reed GW, Roberts B, Wright PF.

J Infect Dis. 1994 Feb;169(2):241-7.

PMID:
8106759
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk